🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.1134
-0.0273 (-19.40%)
At close: Nov 17, 2026, 4:00 PM EST
0.1146
+0.0012 (1.06%)
Pre-market: Nov 18, 2026, 6:59 AM EST

AEON Biopharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
11.423.010.015.169.755.13
Cash & Short-Term Investments
11.423.010.015.169.755.13
Cash Growth
92.63%23023.08%-99.75%-47.08%90.05%-74.57%
Prepaid Expenses
1.150.391.581.060.090.03
Total Current Assets
12.563.41.596.229.845.15
Property, Plant & Equipment
0.861.211.520.590.910.92
Other Long-Term Assets
0.710.950.030.030.030.36
Total Assets
14.135.563.146.8510.786.44

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.980.945.913.397.811.19
Accrued Expenses
3.595.78.129.383.654.01
Current Portion of Long-Term Debt
----70.8715.6
Current Portion of Leases
-0.250.120.280.26-
Total Current Liabilities
4.576.914.1513.0582.5720.8
Long-Term Debt
1.9734.611.69-60.4370.76
Long-Term Leases
0.820.891.15-0.240.52
Other Long-Term Liabilities
4.3818.24.73146.84-0.22
Total Liabilities
11.7460.5931.71159.89143.2492.31

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.010.01000.010.01
Additional Paid-In Capital
483.67415.78403.02381.26187.35187.35
Retained Earnings
-481.3-470.82-431.6-473.6-474.84-422.28
Treasury Stock
-----0.02-0.02
Comprehensive Income & Other
----60.71--
Total Common Equity
2.39-55.03-28.57-153.04-287.5-234.94
Minority Interest
----17.0911.12
Shareholders' Equity
2.39-55.03-28.57-153.04-132.46-85.88
Total Liabilities & Equity
14.135.563.146.8510.786.44

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
2.7935.7512.960.28131.7986.89
Net Cash (Debt)
8.63-32.74-12.944.88-122.05-81.76
Net Cash Growth
------
Net Cash Per Share
0.18-3.30-22.470.06-63.29-46.63
Filing Date Shares Outstanding
59.0825.310.530.551.931.93
Total Common Shares Outstanding
59.0812.110.560.521.931.93
Working Capital
7.99-3.5-12.56-6.83-72.74-15.65
Book Value Per Share
0.04-4.55-51.43-296.54-149.11-121.85
Tangible Book Value
2.39-55.03-28.57-153.04-287.5-234.94
Tangible Book Value Per Share
0.04-4.55-51.43-296.54-149.11-121.85
Machinery
-0.440.440.440.440.13
Leasehold Improvements
-0.070.070.070.070.07
SEC Filings: 10-K · 10-Q